GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wonbiogen Co Ltd (XKRX:307280) » Definitions » Price-to-Free-Cash-Flow

Wonbiogen Co (XKRX:307280) Price-to-Free-Cash-Flow : 16.52 (As of Jun. 19, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wonbiogen Co Price-to-Free-Cash-Flow?

As of today (2024-06-19), Wonbiogen Co's share price is ₩1606.00. Wonbiogen Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩97.23. Hence, Wonbiogen Co's Price-to-Free-Cash-Flow Ratio for today is 16.52.

The historical rank and industry rank for Wonbiogen Co's Price-to-Free-Cash-Flow or its related term are showing as below:

XKRX:307280' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.92   Med: 18.77   Max: 92.07
Current: 16.52

During the past 6 years, Wonbiogen Co's highest Price-to-Free-Cash-Flow Ratio was 92.07. The lowest was 13.92. And the median was 18.77.

XKRX:307280's Price-to-Free-Cash-Flow is ranked better than
74.24% of 330 companies
in the Medical Devices & Instruments industry
Industry Median: 32.535 vs XKRX:307280: 16.52

Wonbiogen Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₩58.57. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩97.23.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Wonbiogen Co was 262.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 161.40% per year.

During the past 6 years, Wonbiogen Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 161.40% per year. The lowest was -20.30% per year. And the median was -3.90% per year.


Wonbiogen Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Wonbiogen Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wonbiogen Co Price-to-Free-Cash-Flow Chart

Wonbiogen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - 1,004.15 - - 20.81

Wonbiogen Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.12 21.88 22.40 20.81 19.04

Competitive Comparison of Wonbiogen Co's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Wonbiogen Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wonbiogen Co's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wonbiogen Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Wonbiogen Co's Price-to-Free-Cash-Flow falls into.



Wonbiogen Co Price-to-Free-Cash-Flow Calculation

Wonbiogen Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1606.00/97.229
=16.52

Wonbiogen Co's Share Price of today is ₩1606.00.
Wonbiogen Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩97.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Wonbiogen Co  (XKRX:307280) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Wonbiogen Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Wonbiogen Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Wonbiogen Co (XKRX:307280) Business Description

Traded in Other Exchanges
N/A
Address
56, 1 Gongdan-ro 5-gil, Gyeongsangbuk-do, Gumi-si, KOR
Wonbiogen Co Ltd is engaged in the manufacturing of medical supplies and instruments. Its product portfolio comprises Therasorb Algi Adhesive, Therasorb AD, Renoderm, Remscar Gel, Meditouch Liquid, and Meditouch Bend, among others.

Wonbiogen Co (XKRX:307280) Headlines

No Headlines